MEDICINE

Regeneron Shares Rocket on Study Results

IBTimes Logo
Shares of Regeneron Paharmaceuticals, Inc. (Nasdaq: REGN) soared Tusday after initial results of a study involving treatment to prevent a leading cause of age-related acquired blindness showed significant results.

Alexza Shares Skyrocket on Drug Trial Results

IBTimes Logo
Drug maker Alexza Pharmaceuticals, Inc. (Nasdaq:ALXA) said that two of its drugs for treating schizophrenic patients showed positive initial results in clinical trials, sending its shares skyrocketing.
IBTimes Logo

Boston Sci Shares Down, Abbot Up on Stent Report

Shares of Boston Scientific (NYSE: BSX) dropped to their lowest price since 2002 on Monday, while shares of Abbott laboratories (NYSE: ABT) rose after a medical study showed that Abbot's stent device was better at treating clogged heart arteries.
More news
IBTimes Logo

Sony Introduces HD Surgery Equipment

Sony Electronics introduced high-definition technology for medical surgery on Monday, rolling out equipment allowing practitioners to see details of patients at never-before resolutions.
IBTimes Logo

Wal-Mart Drug Rollout Four Months Early

Wal-Mart said Thursday it will implement its $4 generic prescription program in Florida tomorrow. The rollout comes four months earlier than originally planned.
IBTimes Logo

World Bank Bird-Flu Grant

The World Bank said on Friday it has approved a $13 million grant to reduce avian influenza threats on poultry in the West Bank and Gaza.
IBTimes Logo

Malaria Takes Toll on African Businesses

Over 70 percent of Sub-Saharan African businesses are negatively affected by malaria, while nearly 40 percent reported a serious impact, a new study released on Thursday stated.
IBTimes Logo

FDA, Barr to meet on morning-after pill status

U.S. health regulators will meet immediately with Barr Pharmaceuticals Inc. about the over-the-counter status of the Plan B contraceptive known as the morning-after pill, according to a report on cable network CNBC Monday.
IBTimes Logo

Schering-Plough profit eclipses expectations

Schering-Plough Corp. on Monday reported quarterly earnings far higher than Wall Street expected, fueled by growing demand for its drugs against cholesterol, arthritis, allergies and hepatitis C.
IBTimes Logo

Shop smart for long-term care insurance

Long-term care insurance isn't new anymore. Insurance companies are getting smarter about how to write their plans, and financial advisers are getting more savvy about how to choose them.
IBTimes Logo

US Approves Merck's Cervical Cancer Vaccine

The first vaccine to prevent cervical cancer won U.S. approval on Thursday when health officials cleared a Merck & Co. Inc. shot to block a sexually transmitted infection that causes the deadly disease.
IBTimes Logo

Bayer Not Seeking Pfizer Consumer Health Unit

German drugs and chemicals group Bayer is not currently considering a bid for Pfizer's consumer healthcare business, an industry source familiar with the matter told Reuters on Saturday.
IBTimes Logo

Generics Face Fight to Crack EU Biotech Market

European generic drug firms hope to lead the world in developing cheap copies of biotech medicines, but industry experts see hurdles ahead and warn that carving out a major market will not happen overnight.
IBTimes Logo

US Issues $1 Bln in Flu Vaccine Contracts

Five companies received more than $1 billion in contracts to develop new and better influenza vaccines, and to make them on U.S. territory, the U.S. Health and Human Services Department said on Thursday.

Pages